With novel payload categories such as degraders, RNA polymerase II inhibitors, immunomodulators, gene silences, and splice modulators entering the clinic, don't miss this opportunity to meet with ...
Daniel Liberto is a journalist with over 10 years of experience working with publications such as the Financial Times, The Independent, and Investors Chronicle. Daniel Rathburn is an editor at ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback